PT85543B - A pharmaceutical preparation for administration by percutaneous absorption and a method for their manufacture - Google Patents

A pharmaceutical preparation for administration by percutaneous absorption and a method for their manufacture

Info

Publication number
PT85543B
PT85543B PT85543A PT8554387A PT85543B PT 85543 B PT85543 B PT 85543B PT 85543 A PT85543 A PT 85543A PT 8554387 A PT8554387 A PT 8554387A PT 85543 B PT85543 B PT 85543B
Authority
PT
Portugal
Prior art keywords
administration
manufacture
pharmaceutical preparation
percutaneous absorption
percutaneous
Prior art date
Application number
PT85543A
Other languages
English (en)
Portuguese (pt)
Other versions
PT85543A (en
Inventor
Masato Azuma
Toshihiro Inoue
Yasuaki Kawano
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of PT85543A publication Critical patent/PT85543A/pt
Publication of PT85543B publication Critical patent/PT85543B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT85543A 1986-08-18 1987-08-17 A pharmaceutical preparation for administration by percutaneous absorption and a method for their manufacture PT85543B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19249286 1986-08-18
JP19249386 1986-08-18
JP8027687 1987-04-01

Publications (2)

Publication Number Publication Date
PT85543A PT85543A (en) 1987-09-01
PT85543B true PT85543B (en) 1989-11-06

Family

ID=27303257

Family Applications (1)

Application Number Title Priority Date Filing Date
PT85543A PT85543B (en) 1986-08-18 1987-08-17 A pharmaceutical preparation for administration by percutaneous absorption and a method for their manufacture

Country Status (18)

Country Link
US (1) US5211943A (no)
EP (1) EP0260452B1 (no)
KR (1) KR880002523A (no)
CN (1) CN87105632A (no)
AR (2) AR241513A1 (no)
AT (1) ATA207887A (no)
AU (1) AU7717587A (no)
BE (1) BE1000477A3 (no)
CS (1) CS601987A2 (no)
DE (1) DE3782594T2 (no)
DK (1) DK424987A (no)
ES (1) ES2052528T3 (no)
FI (1) FI873566A (no)
GR (1) GR871267B (no)
HU (1) HU200923B (no)
NO (1) NO873423L (no)
NZ (1) NZ221465A (no)
PT (1) PT85543B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2886446B2 (ja) * 1994-03-03 1999-04-26 関西ペイント株式会社 塗膜保護用シート
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
US7504114B1 (en) * 1999-04-13 2009-03-17 Hisamitsu Pharmaceuticals Preparations for percutaneous absorption
WO2000067754A1 (en) 1999-05-12 2000-11-16 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
JP2024524660A (ja) 2021-07-10 2024-07-05 オーキリウス ファーマ スポルカ ゼット オグラニクゾナ オドパウイエドジアルノシア 放出調節ニコランジル化合物製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
JPS5910513A (ja) * 1982-07-12 1984-01-20 Nitto Electric Ind Co Ltd 医薬製剤
JPS60184010A (ja) * 1984-03-02 1985-09-19 Nitto Electric Ind Co Ltd 経皮投与用医薬製剤
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
JPH0627068B2 (ja) * 1984-09-22 1994-04-13 中外製薬株式会社 経皮薬剤
JPS61103840A (ja) * 1984-10-26 1986-05-22 Nitto Electric Ind Co Ltd 外皮投与用組成物
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device

Also Published As

Publication number Publication date
EP0260452A1 (en) 1988-03-23
AR241513A1 (es) 1992-08-31
NO873423D0 (no) 1987-08-14
PT85543A (en) 1987-09-01
GR871267B (en) 1987-12-24
DE3782594T2 (de) 1993-06-03
DE3782594D1 (de) 1992-12-17
BE1000477A3 (fr) 1988-12-20
ES2052528T3 (es) 1994-07-16
HUT45397A (en) 1988-07-28
NO873423L (no) 1988-02-19
FI873566A0 (fi) 1987-08-18
US5211943A (en) 1993-05-18
EP0260452B1 (en) 1992-11-11
HU200923B (en) 1990-09-28
ATA207887A (de) 1990-08-15
KR880002523A (ko) 1988-05-09
AU7717587A (en) 1988-02-25
AR240017A1 (es) 1990-01-31
CS601987A2 (en) 1990-08-14
CN87105632A (zh) 1988-03-30
FI873566A (fi) 1988-02-19
DK424987D0 (da) 1987-08-14
DK424987A (da) 1988-02-19
NZ221465A (en) 1989-12-21

Similar Documents

Publication Publication Date Title
PL265416A1 (en) A pharmaceutical preparation for oral administration and a method of its production
GB2093344B (en) Pharmaceutical preparation for percutaneous absorption
GB2095108B (en) Process for obtaining composite pharmaceutical preparation containing a percutaneous medicine
PH25150A (en) Novel pharmaceutical preparation for topical application
PL265417A1 (en) Pharmaceutical preparations for oral administration and a method of their production
EP0255297A3 (en) Azabicyclic compounds, process for their preparation, and their pharmaceutical use
EG18603A (en) A method for the preparation of pharmaceutical composition
EP0245126A3 (en) Percutaneous absorption preparation and process for preparing same
EP0137632A3 (en) Physiologically active substance k-252, process for producing same and a pharmaceutical composition containing same
EP0254584A3 (en) Azabicyclic compounds, process for their preparation, and their pharmaceutical use
DE3662104D1 (en) 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments
IL83152A0 (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes,a process for their preparation,and their use as medicaments
ZA877453B (en) Tetrahydroquinoline derivatives,a process for their preparation,their use and pharmaceutical formulations containing them
PT85543A (en) A pharmaceutical preparation for administration by percutaneous absorption and a method for their manufacture
GR3002266T3 (en) Process for the preparation of single dosage administration forms, and administration forms thus obtained
IL81564A0 (en) Insulin derivatives,a process for their preparation,and pharmaceutical compositions containing them
IL73820A0 (en) 1,3-dioxolanyl derivatives,a process for their preparation,their use and pharmaceutical preparations containing these compounds
IL85395A0 (en) Benzimidazoles,a process for their preparation and pharmaceutical preparations containing these compounds
GR871209B (en) 2,3,4,5,67, - exhydro -2,7 methano -1,5 - benzoxazonin derivatives preparation method and medicaments containing said compound
HUT44753A (en) Process for producing gem-dihalogen-1,8-diamino-4-azaoctane derivatives and pharmaceutical preparations comprising such compounds
ZA876116B (en) Pharmaceutical preparation for administration by percutaneous absorption and method for its manufacture
GB8721313D0 (en) Pharmaceutical preparation
PL267911A1 (en) Foliated pharmaceutical preparation for across-skin administration and the method of its manufacturing
PT81086B (en) Histargin-related compounds a process for their preparation and their use as medicaments
HUT44754A (en) Process for producing gem-dihalogen- and tetrahalogen-1,12-diamino-4,9-diaza-dodecane derivatives and pharmaceutical preparations comprising such compounds